Published in Infect Immun on April 01, 1997
DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect Immun (1998) 1.99
T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun (1997) 1.51
PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period. J Clin Microbiol (2000) 1.35
Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine Immunol (2008) 0.90
Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures. Infect Immun (1998) 0.89
Analysis of mass spectrometry data from the secretome of an explant model of articular cartilage exposed to pro-inflammatory and anti-inflammatory stimuli using machine learning. BMC Musculoskelet Disord (2013) 0.89
The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine Lyme borreliosis. Infect Immun (2013) 0.89
One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin. Clin Vaccine Immunol (2010) 0.89
Antibodies against specific proteins of and immobilizing activity against three strains of Borrelia burgdorferi sensu lato can be found in symptomatic but not in infected asymptomatic dogs. J Clin Microbiol (2000) 0.89
The immunopathology of canine vector-borne diseases. Parasit Vectors (2011) 0.87
The MEK/ERK pathway is the primary conduit for Borrelia burgdorferi-induced inflammation and P53-mediated apoptosis in oligodendrocytes. Apoptosis (2014) 0.84
Inflammatory mediator release from primary rhesus microglia in response to Borrelia burgdorferi results from the activation of several receptors and pathways. J Neuroinflammation (2015) 0.83
Experimental infection of dogs with Borrelia burgdorferi sensu stricto using Ixodes scapularis ticks artificially infected by capillary feeding. Med Microbiol Immunol (2003) 0.81
Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains? Bosn J Basic Med Sci (2015) 0.76
Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA. Parasit Vectors (2015) 0.75
Retrospective clinical and molecular analysis of conditioned laboratory dogs (Canis familiaris) with serologic reactions to Ehrlichia canis, Borrelia burgdorferi, and Rickettsia rickettsii. J Am Assoc Lab Anim Sci (2008) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol (1994) 11.21
Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun (1993) 5.63
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
pHG165: a pBR322 copy number derivative of pUC8 for cloning and expression. Plasmid (1986) 3.15
Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA (1996) 2.88
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81
Treatment of Lyme arthritis. Arthritis Rheum (1994) 2.27
Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol (1990) 2.15
Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet (1993) 2.05
Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol (1995) 1.96
Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. J Infect Dis (1993) 1.88
Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis (1993) 1.87
Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol (1997) 1.83
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med (1979) 1.79
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol (1995) 1.69
Histopathology of Lyme arthritis in LSH hamsters. Am J Pathol (1989) 1.63
Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol (1995) 1.61
Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol (1994) 1.61
In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun (1992) 1.55
IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol (1990) 1.50
Binding of human plasminogen to Borrelia burgdorferi. Infect Immun (1995) 1.42
Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis (1995) 1.38
Molecular cloning of bovine actin-like protein, actin2. Biochem Biophys Res Commun (1992) 1.35
Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun (1996) 1.22
The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids. Arthritis Rheum (1993) 1.11
Evaluation of the detection of Borrelia burgdorferi DNA in urine samples by polymerase chain reaction. Infection (1996) 1.09
Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum (1993) 1.08
Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect Immun (1995) 1.08
Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci U S A (1995) 1.07
Lyme borreliosis in cattle and horses: a review of the literature. Cornell Vet (1992) 1.05
Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs. Vet Microbiol (1993) 1.04
Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis (1993) 1.02
Musculoskeletal manifestations of Lyme disease. Am J Med (1995) 1.01
Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi. J Infect Dis (1993) 1.00
Studies on early events of Borrelia burgdorferi-induced cytokine production in immunodeficient SCID mice by using a tissue chamber model for acute inflammation. Int J Exp Pathol (1995) 0.96
Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J Immunol (1995) 0.95
Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol Int (1996) 0.95
Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro. Am J Respir Cell Mol Biol (1994) 0.93
Ultrastructure of Borrelia burgdorferi in tissues of patients with Lyme disease. J Basic Microbiol (1989) 0.90
Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis. J Invest Dermatol (1991) 0.88
Improved rapid photometric assay for quantitative measurement of PMN migration. J Immunol Methods (1993) 0.87
Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes. Infect Immun (1996) 0.85
Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. J Immunol (1993) 0.85
The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol (1994) 0.84
Neutrophil chemotactic factors in synovial fluids of patients with Lyme disease. Arthritis Rheum (1991) 0.82
Interleukin-8 mediates interleukin-1 alpha-induced neutrophil transcellular migration. Am J Respir Cell Mol Biol (1995) 0.81
Cloning of a canine gene homologous to the human interleukin-8-encoding gene. Gene (1993) 0.79
Inflammatory cytokine production induced by an analogue of muramyl dipeptide MDP-Lys(L18) in rat macrophage cultures and dog synovial fluid. Inflammation (1996) 0.78
Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli. Lymphokine Cytokine Res (1994) 0.78
A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature (1996) 5.07
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
Transcription properties of a cell type-specific TATA-binding protein, TRF. Cell (1997) 2.57
Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia (2000) 2.26
Isolation and characterization of a canine rotavirus. Arch Virol (1982) 2.26
Identification of Sarcocystis capracanis in cerebrospinal fluid from sheep with neurological disease. Vet Parasitol (2012) 2.23
Isolation and immunisation studies of a canine parco-like virus from dogs with haemorrhagic enteritis. Vet Rec (1979) 2.17
Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain (1993) 2.07
Canine distemper virus from diseased large felids: biological properties and phylogenetic relationships. J Gen Virol (1996) 2.06
Pathogenesis of canine distemper. Am J Vet Res (1969) 1.94
Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis (1993) 1.87
Bacteriological variation among Bordetella bronchiseptica isolates from dogs and other species. J Clin Microbiol (1977) 1.86
Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol (1997) 1.83
Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem (2001) 1.81
Pathogenesis of canine bordetellosis. J Infect Dis (1977) 1.74
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology (2008) 1.71
Pathogenicity of morbilliviruses for terrestrial carnivores. Vet Microbiol (1995) 1.62
Horner's syndrome in dogs and cats: 100 cases (1975-1985). J Am Vet Med Assoc (1989) 1.58
Facial neuropathy in dogs and cats: 95 cases (1975-1985). J Am Vet Med Assoc (1987) 1.57
Association between plasma vitamin E concentration and the risk of equine motor neuron disease. Vet J (1997) 1.56
Global epidemiology and public health in the 21st century. Applications of new technology. Ann Epidemiol (1996) 1.55
Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke (2001) 1.55
Gastric function in dogs with naturally acquired gastric Helicobacter spp. infection. J Vet Intern Med (1999) 1.49
Equine motor neuron disease: findings in 28 horses and proposal of a pathophysiological mechanism for the disease. Equine Vet J (1994) 1.48
Enzyme-linked immunosorbent assay for measurement of antibody responses to Dirofilaria immitis in experimentally infected dogs. Am J Vet Res (1981) 1.48
Heterogeneity of hypertrophy in feline hypertrophic heart disease. J Vet Intern Med (1993) 1.46
Comparison of three radiographic methods for diagnosis of hip dysplasia in eight-month-old dogs. J Am Vet Med Assoc (2001) 1.45
Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes. J Gen Microbiol (1993) 1.42
Assessing the efficacy of perioperative carprofen administration in dogs undergoing surgical repair of a ruptured cranial cruciate ligament. J Am Anim Hosp Assoc (2000) 1.42
Genetic diversity of the attachment (H) protein gene of current field isolates of canine distemper virus. J Gen Virol (1997) 1.42
Killing of Brucella abortus by bovine serum. Infect Immun (1988) 1.41
Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 1.41
African wild dogs (Lycaon pictus) endangered by a canine distemper epizootic among domestic dogs near the Masai Mara National Reserve, Kenya. J Wildl Dis (1994) 1.39
Postanaesthetic cerebral necrosis in five horses. Vet Rec (2002) 1.39
Insulin-dependent diabetes mellitus and rainfall. Lancet (1993) 1.39
Abdominal surgery in foals: a review of 119 cases (1977-1994). Equine Vet J (1997) 1.39
Urine sulfated and nonsulfated bile acids as a diagnostic test for liver disease in cats. J Vet Intern Med (2003) 1.38
Pathogenesis of rotavirus infection in various age groups of chickens and turkeys: pathology. Am J Vet Res (1987) 1.37
High resolution refinement of beta-galactosidase in a new crystal form reveals multiple metal-binding sites and provides a structural basis for alpha-complementation. Protein Sci (2000) 1.36
PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period. J Clin Microbiol (2000) 1.35
Early events in canine distemper demyelinating encephalomyelitis. Acta Neuropathol (1979) 1.33
Identification of a locus involved in the utilization of iron by Actinobacillus pleuropneumoniae. FEMS Microbiol Lett (1996) 1.33
Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat Biotechnol (1997) 1.31
Computer-assisted enzyme immunoassays and simplified immunofluorescence assays: applications for the diagnostic laboratory and the veterinarian's office. J Am Vet Med Assoc (1982) 1.31
Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg (1978) 1.30
DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest (1996) 1.28
Evaluation of a commercial ELISA for diagnosis of paratuberculosis in cattle. J Am Vet Med Assoc (2001) 1.27
Equine motor neuron disease; a preliminary report. Cornell Vet (1990) 1.27
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection. Hepatology (1998) 1.26
Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants. Infect Immun (1983) 1.26
Surgical advancement of the larynx (laryngeal tie-forward) as a treatment for dorsal displacement of the soft palate in horses: a prospective study 2001-2004. Equine Vet J (2005) 1.26
Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study. J Infect Dis (2000) 1.25
D-glucaric acid and galactaric acid catabolism by Agrobacterium tumefaciens. J Bacteriol (1970) 1.24
Efficiency and accuracy of disease monitoring systems: application of capture-recapture methods to injury monitoring. Am J Epidemiol (1995) 1.24
Evaluation of a computer-assisted, kinetics-based enzyme-linked immunosorbent assay for detection of coronavirus antibodies in cats. J Clin Microbiol (1983) 1.23
Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study. Vet Pathol (1988) 1.23
Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology (1994) 1.23
Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia (1993) 1.23
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry (1994) 1.21
Comparison and interpretation of diagnostic tests for feline immunodeficiency virus infection. J Am Vet Med Assoc (1991) 1.21
Canine distemper encephalomyelitis: variation with virus strain. J Comp Pathol (1984) 1.21
Dietary fat and carcinogenesis. Mutat Res (1999) 1.21
Evaluation of four 2-dimensional echocardiographic methods of assessing left atrial size in dogs. J Vet Intern Med (2000) 1.20
Characterization of phocid herpesvirus-1 and -2 as putative alpha- and gammaherpesviruses of North American and European pinnipeds. J Gen Virol (1996) 1.20
D-lysine catabolic pathway in Pseudomonas putida: interrelations with L-lysine catabolism. J Bacteriol (1974) 1.19
Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi. Infect Immun (1995) 1.18
Possible initiation of viral encephalomyelitis in dogs by migrating lymphocytes infected with distemper virus. Lancet (1978) 1.17
Epidemiologic and pathologic characteristics of respiratory tract disease in dairy heifers during the first three months of life. J Am Vet Med Assoc (1996) 1.16
Genetic characterization of canine distemper virus in Serengeti carnivores. Vet Immunol Immunopathol (1998) 1.15
Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia (1997) 1.13
Naturally occurring respiratory disease in a kennel caused by Bordetella bronchiseptica. Cornell Vet (1977) 1.12
Measurement of segregating behaviors in experimental silver fox pedigrees. Behav Genet (2007) 1.12
Morbidity from nonrespiratory diseases and mortality in dairy heifers during the first three months of life. J Am Vet Med Assoc (1996) 1.12
Can an external device prevent dorsal displacement of the soft palate during strenuous exercise? Equine Vet J (2005) 1.11
Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus. Infect Immun (1982) 1.09
Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin. Mol Microbiol (1990) 1.09
The reliability of endoscopic examination in assessment of arytenoid cartilage movement in horses. Part I: Subjective and objective laryngeal evaluation. Vet Surg (1991) 1.08
Pasteurella haemolytica leukotoxin: comparison of 51chromium-release, trypan blue dye exclusion, and luminol-dependent chemiluminescence-inhibition assays for sensitivity in detecting leukotoxin activity. Am J Vet Res (1986) 1.07
Histopathological studies of experimental lyme disease in the dog. J Comp Pathol (2005) 1.07
Path analysis of dry period nutrition, postpartum metabolic and reproductive disorders, and mastitis in Holstein cows. J Dairy Sci (1985) 1.07
Canine distemper in black-footed ferrets (Mustela nigripes) from Wyoming. J Wildl Dis (1988) 1.06
Hexuronic acid dehydrogenase of Agrobacterium tumefaciens. J Bacteriol (1969) 1.05
Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J Clin Microbiol (1995) 1.05
Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care (1998) 1.05